MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC-Reference-Cited by-同舟云学术

MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC

Published:2019-02 Issue: Volume:110 Page:656-666
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Quan Jing,Pan Xiang,Li Yawen,Hu Yimin,Tao Lingzhi,Li Zuwei,Zhao Liwen,Wang Jingyao^ORCID,Li Hang,Lai Yulin,Zhou Liang,Lin Canbin,Gui Yaoting,Ye Jing,Zhang Fangting,Lai Yongqing

Funder

Basic Research Project of Peking University Shenzhen Hospital

Clinical Research Project of Peking University Shenzhen Hospital

Science and Technology Development Fund Project of Shenzhen

Clinical Research Project of Shenzhen Health Commission

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference35 articles.

1. Radiotherapy for renal-cell carcinoma;De Meerleer;Lancet Oncol.,2014

2. Chemotherapy in metastatic renal cell carcinoma today? A systematic review;Buti;Anticancer Drugs,2013

3. Everolimus suppresses invasion and migration of renal cell carcinoma by inhibiting FAK activity and reversing epithelial to mesenchymal transition in vitro and in vivo;Wu;Environ. Toxicol.,2017

4. Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics;Sanchez-Mejias;J. Hematol. Oncol.,2015

5. Experimental strategies for microRNA target identification;Thomson;Nucleic Acids Res.,2011

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retraction notice to “MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC” Biomed. Pharmacother. 110(2019) 656–666;Biomedicine & Pharmacotherapy;2024-08

2. Exosomes as novel tools for renal cell carcinoma therapy, diagnosis, and prognosis;Heliyon;2024-06

3. The Screening of microRNAs in Chronic Myeloid Leukemia: A Clinical Evaluation;International Journal of Molecular Sciences;2024-03-16

4. Role of microRNAs in renal cancer diagnostics;Russian Journal for Personalized Medicine;2023-11-23

5. Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application;Molecular Cancer;2023-02-21